Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination
Lilin Wang, … , Amy Bloom, Adrian Bot
Lilin Wang, … , Amy Bloom, Adrian Bot
Published October 15, 2002
Citation Information: J Clin Invest. 2002;110(8):1175-1184. https://doi.org/10.1172/JCI15536.
View: Text | PDF
Article Immunology

Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination

  • Text
  • PDF
Abstract

Research Article

Authors

Lilin Wang, Dan Smith, Simona Bot, Luis Dellamary, Amy Bloom, Adrian Bot

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Effect of various synthetic RNA motifs on specific antibody and T cell i...
Effect of various synthetic RNA motifs on specific antibody and T cell immunity. (a) The impact of various RNA pools (see Table 1) on adaptive immunity was measured in C57BL/6 mice coimmunized with OVA via the respiratory tract. Mice were immunized intratracheally, followed by two boosts 2 weeks apart by intranasal instillation. The antibody response was expressed as mean ± SEM of IgG endpoint titers (n = 4/group). As controls, we used dose-matched OVA in sterile PBS, OVA with CTB, and PBS alone, respectively. (b) Effect of various dsRNA motifs on the induction of antibody response to OVA; results are expressed as in a. The data are representative of two independent experiments. Inset: the ratio of mean IgG2a and IgG1 titers to OVA. The order from left to right is similar to that in the larger graph: PBS OVA, CTB OVA, pC:pG OVA, pI:pC OVA, and pA:pU OVA. (c) Magnitude and profile of T cell response induced by OVA together with various dsRNA motifs in female C57BL/6 mice. The results obtained by ELISpot analysis were expressed as mean ± SEM of the number of IFN-γ and IL-4 spot-forming colonies (SFCs) per spleen (n = 4/group). The results are representative of two independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts